Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: The ENLIGHTEN study

Abstract

QVA149 demonstrated a good safety and tolerability profile, providing rapid and sustained bronchodilation over 52 weeks in patients with moderate-to-severe COPD. ClinicalTrials.gov identifier: NCT01120717.